Добавить новость
smi24.net
News in English
Март
2023

Новости за 15.03.2023

How to Persuade a Billionaire

CounterPunch 

A mid-pandemic survey from Pew found that 55 percent of Americans have no opinion on whether billionaires –  whose wealth doubled during the pandemic – are good or bad for the United States. How do we shift the narrative to convince a larger majority of the dangers of wealth hoarding at the top end of More

Читать дальше...



Royal Challengers Bangalore ropes in Equitas SFB as banking partner for IPL 2023

Economictimes.indiatimes.com 

The RCB team will don the Equitas Small Finance Bank logo on the lead trousers as part of the team’s jersey. This partnership campaign will be aimed to communicate that Equitas has been playing a progressive role in transforming the lives of individuals through their lending and social responsibilities of ‘Beyond Banking’.

India reports 600 Covid cases after 117 days, active cases rise to 4,197

Economictimes.indiatimes.com 

The daily number of Covid cases in India was recorded above 600 after 117 days, while the active cases increased to 4,197, according to the Union Health Ministry data updated on Wednesday. A total of 618 new coronavirus cases were reported in a span of 24 hours while the death toll climbed to 5,30,789 with five deaths.

Indian stock indices back in green on value buying, inflation moderation

BigNewsNetwork.com 

New Delhi [India], March 15 (ANI): Stock indices in India are back in the green largely due to value buying after having declined for a couple of sessions. The recent dip in the indices was due to a slump in the banking and financial stocks following the collapse of two US banks in a matter of two-to-three days. At the time of writing this report, Sensex traded at 58,229.46 points, up 329.27 points or 0.57 per cent, Nifty

NSE SME Systango Tech jumps on debut

Business Standard 

Shares of Systango Technologies were trading at Rs 102.90 at 10.26 IST on the BSE, a premium of 14.33% compared with the issue price of Rs 90.

Abortion pill challenge goes before judge in Texas

Times Union 

A federal judge will hear arguments in a high-stakes court case that could threaten access to medication abortion and blunt the authority of U.S. drug regulators. Judge Matthew Kacsmaryk of Texas is weighing a lawsuit from Christian conservatives aimed at overturning the Food and Drug Administration’s more than 2-decade-old approval of the abortion pill mifepristone. The drug, when used with a second pill, has become the most common method of abortion in the U.S. Wednesday’s hearing is the first in the case... Читать дальше...





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *